Medicare Part D Premiums Will Rise 40% in 2027
Insurers and seniors will face higher costs as the federal government ends its drug plan subsidy program.
Updated on Oct. 8, 2026 in Healthcare
Live Poll
Do you support prioritizing lower government spending over stable premiums for Medicare prescription drug coverage?
The Centers for Medicare and Medicaid Services is terminating the Part D Premium Stabilization Demonstration at the end of 2026. This move will shift private insurers back to traditional market conditions and is projected to increase average monthly standalone drug plan premiums by over 40 percent in January 2027.
Why it matters
The administration is ending this program to eliminate federal intervention and what officials describe as an unnecessary taxpayer-funded bailout for private insurance companies. The reversal effectively shifts costs back to the open market, impacting the budgets of approximately 25 million seniors currently enrolled in these plans.
The subsidy program provided a $16 monthly reduction for 25 million seniors, costing $9.8 billion over its two-year duration. Premiums are now expected to climb by 40% as federal payments to insurers cease.
The players
Centers for Medicare and Medicaid Services
The federal agency responsible for overseeing national health coverage programs and managing the regulatory framework for private insurers.
The details
The termination of the subsidy program forces private insurance providers to absorb costs previously offset by federal payments. By removing these financial supports, CMS aims to restore traditional market dynamics, though the result for beneficiaries will be a significant increase in their monthly standalone drug plan premiums starting in early 2027.
Timeline
2024: The Medicare Part D subsidy program was launched.
2026: The Part D subsidy program was in effect.
November 2026: CMS will release final 2027 premium figures.
January 2027: Medicare Part D premiums are expected to increase.
Market Landscape
The termination of the Medicare Part D Premium Stabilization Demonstration marks a formal pivot from government-subsidized pricing to market-based premiums. This development signals a shift in federal strategy regarding federal payments to private insurers.
Operators in the healthcare and insurance sectors should prepare for a volatile transition period as premium costs reset in early 2027. Businesses that manage benefits or work with senior demographics should monitor the official CMS data release following the November 2026 election.
The takeaway
The end of federal premium supports marks a significant return to market-driven pricing for Medicare beneficiaries. Operators should prepare for a 40 percent premium increase and review the final CMS figures due in November 2026 to understand the full impact on senior populations.
Further reading
For more on evolving federal policies, visit the Healthcare section.
Source note: This article includes information reported by NJTODAY.
Live Poll
Do you support prioritizing lower government spending over stable premiums for Medicare prescription drug coverage?
